Kanabo Partners with British Cannabis to Enhance Digital Health Services

LOS ANGELES- In a significant move to provide enhanced digital health services and specialty medicines, including medicinal cannabis, Kanabo (KNB), a patient-centric provider, has announced a collaborative partnership with British Cannabis. This collaboration will facilitate the availability of pharmacy-grade CBD health supplements to patients. Starting soon, British Cannabis’s CBD products will be procurable through prescriptions on the Group’s online pain management platform, Treat It.

British Cannabis Marketing Director, Steve Batchelor, articulated the company’s enthusiasm about this partnership. “Collaborating with Treat It is an exciting venture. This paves the way for pain patients to avail pharmacy retail brand CBD products through prescribed methods,” said Batchelor. “It marks a progressive step in diversifying choices available to patients and paves the path for medical practitioners to consider naturally-derived supplements, posing as alternatives to conventional pharmaceutical treatments.”

Further amplifying this sentiment, Batchelor emphasized the added benefit for their enduring CBD customers, as they now have an avenue to consult with Treat It’s specialist network. This consultation would enable them to understand individual requirements, including pertinent details like appropriate CBD delivery methods, dosages, and timings.

Treat It, which predominantly focuses on secondary healthcare services, offers a secure digital platform for patients to connect with healthcare experts. This interaction promises a comprehensive diagnosis, ensuing in a tailored patient care plan. Treat It’s healthcare specialists can also suggest treatments, inclusive of medicinal cannabis prescriptions, particularly for individuals enduring chronic pain. With the integration of British Cannabis’s CBD products, Kanabo amplifies its commitment to augmenting the accessibility and affordability of non-traditional pain management solutions, ultimately enriching the patient’s quality of life.

Avihu Tamir, CEO of Kanabo, shared his aspirations for this collaboration. “At Kanabo, our objective remains to broaden the access of medicinal cannabis to a larger patient demographic. Through this partnership, Treat It’s doctors can encompass an extensive range of superior CBD supplements within our telehealth services. We remain zealous about bolstering patient-focused healthcare and the available treatment options. This collaboration signifies just the commencement, with anticipations of unveiling more extensive partnerships in the foreseeable future.”

In a forthcoming development this November, Treat It will feature in Canndr, British Cannabis’s online medicinal cannabis application. This platform empowers patients by allowing them to evaluate, select, and review premier cannabis medications available, attain consultancy insights, and choose from a diverse array of prescribing clinics.